SIGILON THERAPEUTICS INC - COM (SGTX)

CUSIP: 82657L107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
9,125,871
Share change
-125,695
Total reported value
$97,917,000
Price per share
$10.73
Number of holders
51
Value change
-$14,619,322
Number of buys
27
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 82657L107?
CUSIP 82657L107 identifies SGTX - SIGILON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIGILON THERAPEUTICS INC - COM (SGTX) as of Q2 2021

As of 30 Jun 2021, SIGILON THERAPEUTICS INC - COM (SGTX) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,125,871 shares. The largest 10 holders included CANADA PENSION PLAN INVESTMENT BOARD, BlackRock Inc., FMR LLC, HarbourVest Partners LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, STATE OF WISCONSIN INVESTMENT BOARD, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, and AMERICAN CENTURY COMPANIES INC. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.